FDA inspection
RBC Development, LLC. dba RBC Medical Innovations dba Vantage Medtech: FDA inspection ending Jun 5, 2026
FDA inspection 1321692 · No Action Indicated (NAI) · Olathe, Kansas
Key facts
| Inspection ID | 1321692 |
|---|---|
| Firm | RBC Development, LLC. dba RBC Medical Innovations dba Vantage Medtech |
| FEI number | 3043527620 |
| Address | 17100 W 118th Ter |
| City | Olathe |
| State | Kansas |
| ZIP | 66061 |
| Fiscal year | 2026 |
| Inspection end date | Jun 5, 2026 |
| Classification | No Action Indicated (NAI) |
| Project area | Project Evaluation: Devices |
| Product type | Devices |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data